• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立预测模型评估初诊转移性 HER2 阳性乳腺癌患者的预后,并探讨局部手术的获益。

Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery.

机构信息

Department of Oncology, the First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.

Shantou University Medical College, Shantou, Guangdong, China.

出版信息

PLoS One. 2020 Nov 10;15(11):e0242155. doi: 10.1371/journal.pone.0242155. eCollection 2020.

DOI:10.1371/journal.pone.0242155
PMID:33170907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7654787/
Abstract

BACKGROUND

For patients initially diagnosed with metastatic Her2-positive breast cancer (MHBC), we intended to construct a nomogram with risk stratification to predict prognosis and to explore the role of local surgery.

METHODS

We retrieved data from the Surveillance, Epidemiology, and End Results (SEER) database. Kaplan-Meier (KM) method and log-rank test were used for the selection of significant variables. Cox regression analysis and Fine-Gray test were utilized to confirm independent prognostic factors of overall survival (OS) and breast cancer-specific survival (BCSS). A nomogram predicting 1-year, 3-year, and 5-year OS was developed and validated. Patients were stratified based on the optimal cut-off values of total personal score. KM method and log-rank test were used to estimate OS prognosis and benefit from local surgery and chemotherapy.

RESULTS

There were 1680 and 717 patients in the training and validation cohort. Age, race, marriage, T stage, estrogen receptor (ER) status, visceral metastasis (bone, brain, liver and lung) were identified as independent prognostic factors for OS and BCSS, while histology was also corelated with OS. C-indexes in the training and validation cohort were 0.70 and 0.68, respectively. Calibration plots indicated precise predictive ability. The total population was divided into low- (<141 points), intermediate- (142-208 points), and high-risk (>208 points) prognostic groups. Local surgery and chemotherapy brought various degrees of survival benefit for patients with diverse-risk prognosis.

CONCLUSIONS

We constructed a model with accurate prediction and discrimination. It would provide a reference for clinicians' decision-making. Surgery on the primary lesion was recommended for patients with good physical performance status, while further study on optimal surgical opportunity was needed.

摘要

背景

对于最初诊断为转移性 Her2 阳性乳腺癌(MHBC)的患者,我们旨在构建一个具有风险分层的列线图来预测预后,并探讨局部手术的作用。

方法

我们从监测、流行病学和最终结果(SEER)数据库中检索数据。Kaplan-Meier(KM)方法和对数秩检验用于选择显著变量。Cox 回归分析和 Fine-Gray 检验用于确认总生存(OS)和乳腺癌特异性生存(BCSS)的独立预后因素。开发并验证了预测 1 年、3 年和 5 年 OS 的列线图。根据总个人评分的最佳截断值对患者进行分层。KM 方法和对数秩检验用于估计 OS 预后以及局部手术和化疗的获益。

结果

在训练和验证队列中分别有 1680 例和 717 例患者。年龄、种族、婚姻、T 分期、雌激素受体(ER)状态、内脏转移(骨、脑、肝和肺)被确定为 OS 和 BCSS 的独立预后因素,而组织学也与 OS 相关。训练和验证队列的 C 指数分别为 0.70 和 0.68。校准图表明具有精确的预测能力。将总人群分为低风险(<141 分)、中风险(142-208 分)和高风险(>208 分)预后组。局部手术和化疗为不同风险预后的患者带来了不同程度的生存获益。

结论

我们构建了一个具有准确预测和区分能力的模型。它将为临床医生的决策提供参考。对于身体状况良好的患者,建议对原发性病变进行手术,而需要进一步研究最佳手术时机。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/7654787/488ea994a69b/pone.0242155.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/7654787/bf5ed51b8407/pone.0242155.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/7654787/429b583a6420/pone.0242155.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/7654787/6ce4fa2cea4f/pone.0242155.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/7654787/ddf1dedc77d0/pone.0242155.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/7654787/58375b268f9d/pone.0242155.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/7654787/c2ac38a2d478/pone.0242155.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/7654787/488ea994a69b/pone.0242155.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/7654787/bf5ed51b8407/pone.0242155.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/7654787/429b583a6420/pone.0242155.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/7654787/6ce4fa2cea4f/pone.0242155.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/7654787/ddf1dedc77d0/pone.0242155.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/7654787/58375b268f9d/pone.0242155.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/7654787/c2ac38a2d478/pone.0242155.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/7654787/488ea994a69b/pone.0242155.g007.jpg

相似文献

1
Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery.建立预测模型评估初诊转移性 HER2 阳性乳腺癌患者的预后,并探讨局部手术的获益。
PLoS One. 2020 Nov 10;15(11):e0242155. doi: 10.1371/journal.pone.0242155. eCollection 2020.
2
Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.基于 SEER 的人群研究:列线图预测乳腺癌脑转移的生存。
World Neurosurg. 2019 Aug;128:e823-e834. doi: 10.1016/j.wneu.2019.04.262. Epub 2019 May 13.
3
Prognostic nomograms for breast cancer with lung metastasis: a SEER-based population study.基于 SEER 的人群研究:肺转移乳腺癌的预后列线图。
BMC Womens Health. 2024 Jan 3;24(1):16. doi: 10.1186/s12905-023-02848-5.
4
A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study.一个用于预测小细胞肺癌脑转移患者生存的新列线图和风险分类系统:一项大型基于人群的研究。
BMC Cancer. 2021 May 29;21(1):640. doi: 10.1186/s12885-021-08384-5.
5
Nomogram for Predicting the Overall Survival of Patients With Breast Cancer With Pathologic Nodal Status N3.预测 N3 腋窝淋巴结转移状态乳腺癌患者总生存的列线图
Clin Breast Cancer. 2020 Dec;20(6):e778-e785. doi: 10.1016/j.clbc.2020.06.002. Epub 2020 Jun 7.
6
Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer.列线图预测淋巴结阳性、管腔 A 型乳腺癌患者的生存情况。
BMC Cancer. 2021 Aug 28;21(1):965. doi: 10.1186/s12885-021-08642-6.
7
Comparison of breast-conserving surgery without radiotherapy and mastectomy in the treatment of elderly patients with early breast cancer: A PSM and SEER database study.保乳手术与改良根治术治疗老年早期乳腺癌的比较:倾向评分匹配和 SEER 数据库研究。
Cancer Med. 2023 Jul;12(14):15229-15245. doi: 10.1002/cam4.6210. Epub 2023 Jun 3.
8
Association between socioeconomic factors at diagnosis and survival in breast cancer: A population-based study.诊断时社会经济因素与乳腺癌生存的关系:一项基于人群的研究。
Cancer Med. 2020 Mar;9(5):1922-1936. doi: 10.1002/cam4.2842. Epub 2020 Jan 20.
9
A nomogram and risk stratification system for predicting survival in T1-2N0-1 breast cancer patients with liver metastasis in females: a population-based study.基于人群的研究:用于预测女性 T1-2N0-1 期乳腺癌伴肝转移患者生存的列线图和风险分层系统。
Biomed Eng Online. 2024 Aug 12;23(1):81. doi: 10.1186/s12938-024-01274-4.
10
Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.年龄对乳腺癌患者预后的影响:一项基于监测、流行病学和最终结果(SEER)18数据库的人群研究
PLoS One. 2016 Oct 31;11(10):e0165409. doi: 10.1371/journal.pone.0165409. eCollection 2016.

引用本文的文献

1
Development of a prognostic risk stratification model for HER2-positive breast cancer brain metastasis and its implications in guiding treatment decisions.HER2阳性乳腺癌脑转移预后风险分层模型的建立及其在指导治疗决策中的意义。
Sci Rep. 2025 Jul 2;15(1):22623. doi: 10.1038/s41598-025-06645-y.
2
Development of prognostic models for HER2-positive metastatic breast cancer in females: a retrospective population-based study.女性HER2阳性转移性乳腺癌预后模型的开发:一项基于人群的回顾性研究。
BMC Womens Health. 2024 Dec 31;24(1):675. doi: 10.1186/s12905-024-03526-w.
3
Identification of potential diagnostic and prognostic biomarkers for breast cancer based on gene expression omnibus.

本文引用的文献

1
Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.《NCCN 肿瘤学临床实践指南:乳腺癌》第 3.2020 版
J Natl Compr Canc Netw. 2020 Apr;18(4):452-478. doi: 10.6004/jnccn.2020.0016.
2
Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer.转移性乳腺癌患者局部区域手术治疗生存获益的个体化预测
Front Oncol. 2020 Feb 18;10:148. doi: 10.3389/fonc.2020.00148. eCollection 2020.
3
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.
基于基因表达综合数据库鉴定乳腺癌潜在的诊断和预后生物标志物。
World J Clin Cases. 2023 Sep 26;11(27):6344-6362. doi: 10.12998/wjcc.v11.i27.6344.
全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 29 种癌症组别的伤残调整生命年数:1990 至 2017 年全球疾病负担研究的系统分析。
JAMA Oncol. 2019 Dec 1;5(12):1749-1768. doi: 10.1001/jamaoncol.2019.2996.
4
Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial.原发转移性乳腺癌乳房切除术的影响:前瞻性随机 III 期 ABCSG-28 POSYTIVE 试验的结果。
Ann Surg. 2019 Jun;269(6):1163-1169. doi: 10.1097/SLA.0000000000002771.
5
Prognostic models for breast cancer: a systematic review.乳腺癌预后模型:系统评价。
BMC Cancer. 2019 Mar 14;19(1):230. doi: 10.1186/s12885-019-5442-6.
6
Prognostic nomogram for patients with non-metastatic HER2 positive breast cancer in a prospective cohort.HER2 阳性非转移性乳腺癌患者的前瞻性队列研究预后列线图。
Int J Biol Markers. 2019 Mar;34(1):41-46. doi: 10.1177/1724600818824786. Epub 2019 Mar 11.
7
Breast Cancer Treatment: A Review.乳腺癌治疗:综述。
JAMA. 2019 Jan 22;321(3):288-300. doi: 10.1001/jama.2018.19323.
8
Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis.在一项大型多中心队列研究中,新转移的乳腺癌中局部区域治疗原发性肿瘤对生存的影响:倾向评分匹配分析。
Ann Surg Oncol. 2019 Feb;26(2):356-365. doi: 10.1245/s10434-018-6831-9. Epub 2018 Dec 11.
9
Primary tumor resection in stage IV breast cancer: A systematic review and meta-analysis.IV 期乳腺癌的原发肿瘤切除术:系统评价和荟萃分析。
Eur J Surg Oncol. 2018 Oct;44(10):1504-1512. doi: 10.1016/j.ejso.2018.08.002. Epub 2018 Aug 11.
10
Score for the Survival Probability in Metastasis Breast Cancer: A Nomogram-Based Risk Assessment Model.转移乳腺癌生存概率评分:基于列线图的风险评估模型。
Cancer Res Treat. 2018 Oct;50(4):1260-1269. doi: 10.4143/crt.2017.443. Epub 2018 Jan 2.